Artoss distributes NanoBone® Bone Graft, a nanotechnology that harnesses the body’s capacity to heal bone. FDA has cleared NanoBone for use as a standalone graft, including for spinal fusion, due to its ability to create an osteogenic environment that replicates the architecture and chemistry of natural bone. NanoBone performs as well as the gold standards for bone grafting, with lower risks than autograft and at a lower price than BMP or cellular allograft. It has been used successfully for more than ten years in over 100,000 cases.
Exhibiting Company is Associated with these Practice Area(s): Foot and Ankle, General Orthopaedic Surgery, Musculoskeletal Oncology, Spine, Trauma, Shoulder and Elbow, Sports Medicine, Hand and Wrist
Learning Experience(s) available in this booth are: Attendees will learn the about the nanotechnology breakthroughs that enable NanoBone Bone Graft to function as a standalone graft with equivalent clinical outcomes to autograft.